New York, NY · Founded 2022 · Privately Held (backing)
Developer of prognostic and predictive digital diagnostic assays designed to help doctors select the optimal treatment for all patients. Ataraxis (Diagnostic Equipment) is based in New York, NY and was founded in 2022. Its last reported valuation was $68 million in Mar 2025. It has raised $24.1 million.
Last reported valuation
$68.0M
Oct 2026
Priced at
—
Total raised
$24.1M
Last round
—
Cap table — not yet on record
Ataraxis (Diagnostic Equipment)'s share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ataraxis (Diagnostic Equipment) with a free account
·The complete investor list: 12 names
·Watch Ataraxis (Diagnostic Equipment): the Monday email on marks, rounds and moves
